1729
236
173
108
106
85
73
65
62
53
48
45
44
40
39
39
36
35
33
32
31
31
30
29
26
23
23
22
20
20
19
18
18
17
16
16
15
14
13
13
12
12
12
12
11
10
10
10
9
9
8
8
8
7
6
6
6
6
6
5
5
5
5
5
5
5
5
5
5
5
5
5
4
4
4
4
4
4
4
4
4
4
4
4
4
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
11079
1107
2679
267
2859
285
Journal of The National Comprehensive Cancer Network
HSR26-228: BTK Inhibitor (Bruton Tyrosine Kinase Inhibitor) Plus Anti-CD20 Antibody Therapy Surpasses CIT (Chemoimmunotherapy) in Frontline CLL (Chronic Lymphocytic Leukemia) With Obinutuzumab Drives Deeper Remissions: A Meta-Analysis of Randomized Controlled Trials
PDF的下载单位、IP信息已删除
(2025-6-4)